Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invigor Medical vs Lyfe Rx

By GLP-1 ScorecardUpdated

Invigor Medical
Site position #10

Higher grade

Lyfe Rx
Site position #478

Lower grade

Score comparison

Invigor Medical has the higher recorded score — 86.1/100 to 55.9/100.

Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established pharmacy operator with steady mid-market pricing and a broad catalog.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueInvigor Medical +34
84
50
Dose & formulationInvigor Medical +20
84
64
Clinical oversightInvigor Medical +33
88
55
Labs & monitoringInvigor Medical +34
86
52
FulfillmentInvigor Medical +26
88
62
Contract termsInvigor Medical +35
90
55
Invigor Medical · top barLyfe Rx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricInvigor MedicalLyfe Rx
WeighScore86.1/10055.9/100
GradeBC
Site position#10#478
Semaglutide$199/mo$225/mo (compounded)
Tirzepatide$339/mo$299/mo (compounded)
CoverageNot disclosedCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Invigor Medical

Site position #10 · B

Strengths

  • Mid-market pricing on both molecules
  • Long-running operator

What to consider

  • No explicit states list
  • Compounded only
Lyfe Rx

Site position #478 · C

FDAWarning letter issued to Lyfe Rx in September 2025. See the FDA warning-letter database.

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Delivery to all 50 states with 1–3 day pharmacy turnaround

What to consider

  • No visible LegitScript or PCAB accreditation
  • Also sells non-prescription supplements ('Tirzepatide Weight Loss Supplement', 'Lipo Burn')
  • Shopify-based e-commerce storefront — less clinical infrastructure
  • FDA issued Lyfe Rx a warning letter in September 2025; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard